Deoxycoformycin (dCF), a potent and tightly binding ADA inhibitor was proposed to balance the signals through adenosine receptors as beneficial in late stage acute respiratory distress syndrome [61,62]. Here, ADA is linked to acute respiratory distress syndrome.